My notes are very similar to this. I'm expecting a $3.40 share...

My notes are very similar to this. I'm expecting a $3.40 share price post successful phase 2. With the already established saftey profile and compelling historical annimal studies showing efficacy, I'm expecting a decent post ph2 result. Hopefully mgmt succesfully execute a decent size transaction to enable funds for the proceeding phase 2 registration trial. Invex has most of the foundations to rapidly add value over the next 24mths. I'm eagerly awaiting a few more patents to come through then all the boxes are ticked.